Singapore, Singapore--(Newsfile Corp. - November 2, 2021) - DeBio Network is a decentralized anonymous-first medical and biomedical platform created for users who want to anonymously submit to tests and various medical samples from the comfort of their homes. DeBio Network is created using Substrate, a blockchain framework behind the Polkadot & Kusama Ecosystem. DeBio Network's blockchain will be an Appchain on the Octopus Network, a Substrate relay chain on the NEAR Protocol.
DeBio
To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/8203/101686_e9e692ef149ac8ee_001full.jpg
Online biomedical testing has become increasingly popular, more so due to the recent coronavirus pandemic. With a proven demand worldwide and an incredible market potential, remote medical technologies are proving increasingly attractive to patients wanting to limit contact and travel times.
"DeBio assures the sovereignty of your biomedical data," Pandu Sastrowardoyo, the CEO, was quoted as saying. "Web3 technologies assure that you can even monetize your data while keeping your identity private."
DeBio Network contributes to solving distance, availability, contact challenges and is already working on the release of their platform. Recently the DeBio Network team concluded their funding rounds which resulted in a 5x oversubscription, raising a whopping $850,000 in the process.
The DeBio Network team announced three rounds of investment:
- Seed investment round of $250,000
- Strategic investment round of $500,000
- Private investment round of $100,000
During the investment rounds, DeBio Network received a lot of interest from investors, and the private round was closed much earlier than planned due to strong demand.
Currently, the DeBio Network team is working on their Initial Dex Offering (IDO). This will be the last chance for investors to buy $DBIO at a bargain price before it is listed on major exchanges. Subsequently, DeBio Network has also announced a partnership with Skyward.finance and Ref.finance for the upcoming IDO.
Skyward.finance is an open-source permissionless launchpad for NEAR projects. Skyward.finance allows tokens to launch without any prior liquidity. The DeBio Network team chose Skyward.finance because of their convenience, reliability, and commitment to fairness in regards to price discovery.
Ref.finance is the first major DeFi platform in the NEAR ecosystem. The DeBio Network team is planning to allow for the exchange of $DBIO and $NEAR tokens immediately following the IDO. Ref.finance will also provide bonuses for farmers and LPs.
The DeBio Network team announced that the IDO will take place in November 2021.
If you are interested in this project, you can learn more about it on the official resources:
Website: https://www.debio.network/
Twitter: http://twitter.com/debio_network
Telegram: https://t.me/debionetwork
Medium: https://blog.debio.network/
Media Contact:
DAOGENICS, LTD ("DeBio Network")
Singapore
Email: marketing@debio.network
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/101686
